ES2054005T3 - Composiciones que contienen acido 2-(2,6-dicloro-3-metilfenilamino)-benzoico y su uso en el tratamiento de periodontitis destructiva. - Google Patents

Composiciones que contienen acido 2-(2,6-dicloro-3-metilfenilamino)-benzoico y su uso en el tratamiento de periodontitis destructiva.

Info

Publication number
ES2054005T3
ES2054005T3 ES89308340T ES89308340T ES2054005T3 ES 2054005 T3 ES2054005 T3 ES 2054005T3 ES 89308340 T ES89308340 T ES 89308340T ES 89308340 T ES89308340 T ES 89308340T ES 2054005 T3 ES2054005 T3 ES 2054005T3
Authority
ES
Spain
Prior art keywords
treatment
methylphenylamine
dichloro
benzoic acid
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89308340T
Other languages
English (en)
Inventor
Joseph Degant Clark Jr
Ivan Theodore Myers
Kenneth Shyer Kornman
Stanley Carl Hold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of ES2054005T3 publication Critical patent/ES2054005T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Bulkheads Adapted To Foundation Construction (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE DESCRIBEN COMPOSICIONES Y SALES FISIOLOGICAMENTE ACEPTABLES QUE SON EFECTIVOS PARA INHIBIR LA CONVERSION DE LA GENGIVITIS EN PERIDONTITIS Y DE ESTA MANERA ES UTIL EN EL TRATAMIENTO DE LAS ENFERMEDADES PERIODONTALES DESTRUCTIVAS. EL AGENTE TERAPEUTICO PUEDE APLICARSE DIRECTAMENTE SOBRE EL TEJIDO GINGIVAL SOBRE UN COMPUESTO FARMECEUTICO ADMINISTRABLE DE FORMA TOPICA Y PUEDE INTRODUCIRSE Y LIBERARSE EN LA CAVIDAD BUCAL PARA SU CONTACTO CON EL TEJIDO GINGIVAL A TRAVES DEL MOVIMIENTO DEL FLUIDO PRESENTE EN LA BOCA.
ES89308340T 1988-10-06 1989-08-17 Composiciones que contienen acido 2-(2,6-dicloro-3-metilfenilamino)-benzoico y su uso en el tratamiento de periodontitis destructiva. Expired - Lifetime ES2054005T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/254,526 US4933172A (en) 1988-10-06 1988-10-06 Method of and compositions for treating destructive periodontal disease

Publications (1)

Publication Number Publication Date
ES2054005T3 true ES2054005T3 (es) 1994-08-01

Family

ID=22964617

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89308340T Expired - Lifetime ES2054005T3 (es) 1988-10-06 1989-08-17 Composiciones que contienen acido 2-(2,6-dicloro-3-metilfenilamino)-benzoico y su uso en el tratamiento de periodontitis destructiva.

Country Status (17)

Country Link
US (1) US4933172A (es)
EP (1) EP0367382B1 (es)
JP (1) JPH02145516A (es)
KR (1) KR900005970A (es)
AT (1) ATE85520T1 (es)
AU (1) AU615110B2 (es)
DE (1) DE68904872T2 (es)
DK (1) DK491689A (es)
ES (1) ES2054005T3 (es)
FI (1) FI894710A7 (es)
GR (1) GR3007246T3 (es)
IE (1) IE893207L (es)
NO (1) NO893970L (es)
NZ (1) NZ230902A (es)
PH (1) PH27264A (es)
PT (1) PT91906B (es)
ZA (1) ZA897596B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
US5230895A (en) * 1990-05-01 1993-07-27 Copley Pharmaceutical Inc. Sustained released delivery system for use in the periodontal pocket
US5318960A (en) * 1992-06-03 1994-06-07 Frank Toppo System for transdermal delivery of pain relieving substances
US5807541A (en) * 1996-04-22 1998-09-15 Sepracor, Inc. NSAID/fluoride periodontal compositions and methods
IT1291278B1 (it) * 1996-07-05 1999-01-07 Errekappa Euroterapici S P A Preparazione farmaceutica a base di nimesulide per uso topico
US5792446A (en) * 1997-02-18 1998-08-11 Collagenex Pharmaceuticals, Inc. Delivery system for administering dentin-hypersensitivity-ameliorating compositions
IT1291895B1 (it) 1997-04-24 1999-01-21 Errekappa Euroterapici S P A Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
IT1315274B1 (it) * 1999-12-29 2003-02-03 Cip Ninety Two 92 Sa Composizioni farmaceutiche per la somministrazione localizzata nelcavo orale di farmaci antiinfiammatori non stereoidei utili per la
US20040077609A1 (en) * 2001-01-16 2004-04-22 Michael Rubin Oral composition containing NSAIDs and essential oils
JP4229842B2 (ja) * 2002-02-22 2009-02-25 ルバンス セラピュティックス インク． Ｌ−アルギニンオリゴマーを含む化粧品処方
CA2506232A1 (en) * 2002-11-18 2004-06-03 Celgene Corporation Methods of using and compositions comprising (+)-3-(3,4-dimethoxy-phenyl)-3-(1-oxo-1,3-dihydro-isoindol-2-yl)-propionamide
EP2260828B1 (en) 2004-11-16 2015-08-05 3M Innovative Properties Co. Dental Fillers, Methods, Compositions Including a Caseinate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0647532B2 (ja) * 1983-08-31 1994-06-22 ジ アツプジヨン カンパニ− 歯槽骨吸収の治療
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4780463A (en) * 1984-12-26 1988-10-25 Analgesic Associates Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same
US4722938A (en) * 1984-12-26 1988-02-02 Analgesic Associates Methods for using musculoskeletal relaxants
IT1216233B (it) * 1986-07-02 1990-02-22 Menarini Sas Utilizzazione della forma farmaceutica 'gel'contenente acido n (2,6 dicloro m tolil) antranilico (acido meclofenamico) impiegabile in terapia per uso topico.
US4843099A (en) * 1987-07-20 1989-06-27 Colgate-Palmolive Company Device and composition for treatment of the gums

Also Published As

Publication number Publication date
DE68904872D1 (de) 1993-03-25
ATE85520T1 (de) 1993-02-15
IE893207L (en) 1990-04-06
FI894710A0 (fi) 1989-10-05
GR3007246T3 (es) 1993-07-30
PT91906A (pt) 1990-04-30
JPH02145516A (ja) 1990-06-05
KR900005970A (ko) 1990-05-07
DE68904872T2 (de) 1993-06-17
AU4247789A (en) 1990-04-12
PH27264A (en) 1993-05-04
EP0367382A1 (en) 1990-05-09
FI894710A7 (fi) 1990-04-07
PT91906B (pt) 1995-05-31
US4933172A (en) 1990-06-12
DK491689D0 (da) 1989-10-05
NO893970D0 (no) 1989-10-05
AU615110B2 (en) 1991-09-19
NO893970L (no) 1990-04-09
ZA897596B (en) 1990-07-25
NZ230902A (en) 1991-11-26
DK491689A (da) 1990-04-07
EP0367382B1 (en) 1993-02-10

Similar Documents

Publication Publication Date Title
ES2054005T3 (es) Composiciones que contienen acido 2-(2,6-dicloro-3-metilfenilamino)-benzoico y su uso en el tratamiento de periodontitis destructiva.
EP0264660A3 (en) Use of a dental material for combating caries and periodontosis
PE12991A1 (es) Composicion dentifrica oral antiplaca antibacterial
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
DE60230021D1 (de) Systeme zur verabreichung eines kosmetischen und/oder therapeutischen wirkstoffes an mundoberflächen
ES2082833T3 (es) Uso de monooleina en el tratamiento de la bolsa periodontal.
ES2051718T3 (es) Agente para el cuidado dental.
ES2103506T3 (es) Utilizacion de acidos hidroxicarboxilicos y sus derivados para la preparacion de composiciones dermatologicas topicas para el tratamiento de arrugas.
ATE178786T1 (de) Dentin desensibilisierende mittel
AR029542A1 (es) Composiciones para el cuidado bucal que contienen clorito y sus metodos
MX9307358A (es) Composicion para higiene bucal.
ATE69160T1 (de) Verwendung von usninsaeure oder deren derivaten bei der behandlung von zahnfaeule.
PT1035844E (pt) Utilizacao de poliois no combate a infeccoes por leveduras e preparacoes de poliol para a referida utilizacao
PE2096A1 (es) Metodos y composiciones para tratar la periodontitis adulta
ITRM920900A1 (it) Formulazione proteica coadiuvante nella prevenzione e cura delle parodontiti e di altre patologie batteriche del cavo orale.
MX173156B (es) Composiciones para tratar o evitar la placa dental o enfermedades gingivales o periodontales de la cavidad oral en humanos o animales inferiores
DK1194109T3 (da) Topiske formuleringer omfattende hud-gennemtrængningsmidler samt anvendelse deraf
ES2071309T3 (es) Medios que tienen un efecto microbial y una tendencia pequeña o eliminada completamente para desarrollar reacciones por alergias de contacto o efectos toxicos y su utilizacion por ejemplo en productos para el tratamiento de piel y heridas.
ES2086536T3 (es) Uso de ketorolaco para el tratamiento de la enfermedad periodontal.
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
ES2124926T3 (es) Uso de desoxipergualina para la preparacion de un medicamento para el tratamiento de enfermedades inflamatorias e hiperreactivas.
CO4230014A1 (es) Composicion oral a base de n-metilpirrolidona
ES2178953B1 (es) Producto dentifrico.
KR960016875A (ko) 이부 프로펜을 함유한 치약 조성물

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 367382

Country of ref document: ES